
- Pharmaceutical Commerce - November/December 2010
AmerisourceBergen elevates Steve Collis to president and COO
The Big Three distributor’s board of directors has appointed Collis, currently president of AmerisourceBergen Drug Corp. (ABDC, the pharma wholesaling arm of the company) to president and chief operating officer of the parent. He will report to R. David Yost, AmerisourceBergen’s CEO, who previously also held the title of president.
Collis is now responsible for all AmerisourceBergen business units, including ABDC, AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Packaging Group (ABPG) and AmerisourceBergen Consulting Services (ABCS). ABSG and ABCS previously reported to Yost, and ABPG previously reported to Michael DiCandilo, EVP and CFO.
Collis, who has been at AmerisourceBergen for 16 years, has been president of ABSG since 1999; that unit is now a fast-growing, $16-billion part of the company. This month, the company also announced its FY2010 results, with revenue reaching a new record, $78.0 billion, up 8.6%, and gross profit of $2.4 billion, up 12.2%.
Articles in this issue
almost 15 years ago
HDMA 2010-2011 Factbook Updates Distributor IT Effortsalmost 15 years ago
UPS and Endo Pharmaceuticals Go Live With Controlled-Substances Orderingalmost 15 years ago
AmerisourceBergen Specialty Group Reconfigures Cubixx Medical Cabinetalmost 15 years ago
Thermo Fisher Scientific Upgrades Its TruScan Materials-Testing Technologyalmost 15 years ago
What's the Buzz About Multichannel Marketing?almost 15 years ago
The Struggle to Get Anti-Infectives on a Faster Track to Commercializationalmost 15 years ago
Oral Liquids Hold Steady as a Drug Delivery Methodalmost 15 years ago
Bringing New Science, and New Partners, Into the Drug Development ProcessNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.